VitaSpring Biomedical Co. Ltd.
VSBC
$1.00
$0.000.00%
OTC PK
| 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | 10/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 4.98M | 5.18M | 6.57M | 5.61M | 2.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.98M | 5.18M | 6.57M | 5.61M | 2.37M |
| Cost of Revenue | 2.95M | 3.13M | 4.18M | 3.55M | 1.66M |
| Gross Profit | 2.03M | 2.05M | 2.39M | 2.06M | 713.20K |
| SG&A Expenses | 844.30K | 818.90K | 736.70K | 575.80K | 763.20K |
| Depreciation & Amortization | 11.40K | 11.40K | 8.40K | 4.60K | 800.00 |
| Other Operating Expenses | 400.00 | 400.00 | 700.00 | 700.00 | 300.00 |
| Total Operating Expenses | 3.80M | 3.96M | 4.92M | 4.13M | 2.42M |
| Operating Income | 1.18M | 1.22M | 1.65M | 1.48M | -51.10K |
| Income Before Tax | 1.18M | 1.23M | 1.65M | 1.48M | -52.90K |
| Income Tax Expenses | 246.00K | 291.60K | 321.90K | 190.60K | -56.30K |
| Earnings from Continuing Operations | 0.94 | 0.94 | 1.33 | 1.29 | 0.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 936.00K | 936.50K | 1.33M | 1.29M | 3.40K |
| EBIT | 1.18M | 1.22M | 1.65M | 1.48M | -51.10K |
| EBITDA | 1.19M | 1.24M | 1.66M | 1.31M | -226.60K |
| EPS Basic | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 826.09M | 825.02M | 823.96M | 822.86M | 870.64M |
| Average Diluted Shares Outstanding | 826.09M | 825.02M | 823.96M | 822.86M | 870.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |